has been refreshed! Take a tour.
  • COVID-19
  • Contraindications & Precautions

My patient had an episode of myocarditis 10 years ago. Is a history of myocarditis a contraindication or precaution to vaccination with an mRNA or Novavax vaccine?

CDC guidance is that people who have a history of completely resolved myocarditis or pericarditis unrelated to COVID-19 vaccination (e.g., due to SARS-CoV-2 or other viruses) may receive any age-appropriate COVID-19 vaccine that is FDA-approved or FDA-authorized. “Complete resolution” includes resolution of symptoms attributed to myocarditis or pericarditis, as well as no evidence of ongoing heart inflammation or sequelae as determined by the person’s clinical team.

For people who have a history of myocarditis associated with MIS-C or MIS-A following SARS-CoV-2 infection, see CDC’s interim clinical considerations concerning COVID-19 vaccination and MIS-C and MIS-A:

Complete and current clinical considerations for COVID-19 vaccination of patients with a history of myocarditis are available from CDC here:

For additional information about myocarditis and mRNA COVID-19 vaccines, visit

Last reviewed: October 26, 2023

This page was updated on .